- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Buried Treasure: The Stealth Issue of E-Business Taxation
It}s generally accepted that pharmaceutical companies need to transform their business processes to remain competitive in the global economy. Shareholders, analysts, partners, suppliers, and customers consistently applaud announcements about information technology (IT) improvements. But managing the necessary changes to exploit the value of e-business initiatives is more problematic than many companies realize, requiring a focused management effort, within which is buried the stealth issue of e-business taxation.
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
